Mythic Therapeutics

Details:

Details about Mythic Therapeutics

Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.

[email protected]

Employees:

Employees at Mythic Therapeutics

Nimish Gera

Vice President, Biologics at Mythic Therapeutics

Benjamin Hutchins

Vice President Technical Operations at Mythic Therapeutics

Helen Chalk

Vice President Clinical Operations at Mythic Therapeutics

Lihui Xu

Director, Antibody Engineering at Mythic Therapeutics

Archchana Mathura

Corporate Controller at Mythic Therapeutics

Ji Lee

Associate Scientist II- Protein Production at Mythic Therapeutics

Brian Fiske

Founder and CSO at Mythic Therapeutics

Lin Nie

Principal Scientist (Biologics Team) at Mythic Therapeutics